Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.

Dunn GP, Spiliopoulos K, Plotkin SR, Hornicek FJ, Harmon DC, Delaney TF, Williams Z.

J Neurosurg. 2013 Jan;118(1):142-8. doi: 10.3171/2012.9.JNS101610. Epub 2012 Oct 26.

PMID:
23101443
2.

Association of tumor location, extent of resection, and neurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors.

Safaee M, Parsa AT, Barbaro NM, Chou D, Mummaneni PV, Weinstein PR, Tihan T, Ames CP.

Neurosurg Focus. 2015 Aug;39(2):E5. doi: 10.3171/2015.5.FOCUS15183.

PMID:
26235022
3.

Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.

Chou D, Bilsky MH, Luzzati A, Fisher CG, Gokaslan ZL, Rhines LD, Dekutoski MB, Fehlings MG, Ghag R, Varga P, Boriani S, Germscheid NM, Reynolds JJ; AOSpine Knowledge Forum Tumor.

J Neurosurg Spine. 2017 Mar;26(3):291-298. doi: 10.3171/2016.8.SPINE151548. Epub 2016 Nov 11.

PMID:
27834629
4.

Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.

LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S.

Ann Surg Oncol. 2013 Jan;20(1):66-72. doi: 10.1245/s10434-012-2573-2. Epub 2012 Aug 10.

5.

Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.

Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH.

Eur J Surg Oncol. 2013 Jan;39(1):46-52. doi: 10.1016/j.ejso.2012.09.001. Epub 2012 Oct 18.

PMID:
23084090
6.

Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).

Valentin T, Le Cesne A, Ray-Coquard I, Italiano A, Decanter G, Bompas E, Isambert N, Thariat J, Linassier C, Bertucci F, Bay JO, Bellesoeur A, Penel N, Le Guellec S, Filleron T, Chevreau C.

Eur J Cancer. 2016 Mar;56:77-84. doi: 10.1016/j.ejca.2015.12.015. Epub 2016 Jan 26.

PMID:
26824706
7.

Malignant peripheral nerve sheath tumors of the trigeminal nerve: a systematic review of 36 cases.

Schmidt RF, Yick F, Boghani Z, Eloy JA, Liu JK.

Neurosurg Focus. 2013 Mar;34(3):E5. doi: 10.3171/2012.11.FOCUS12292. Review.

PMID:
23451818
8.

Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.

Zehou O, Fabre E, Zelek L, Sbidian E, Ortonne N, Banu E, Wolkenstein P, Valeyrie-Allanore L.

Orphanet J Rare Dis. 2013 Aug 23;8:127. doi: 10.1186/1750-1172-8-127.

9.

Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.

Ziadi A, Saliba I.

Auris Nasus Larynx. 2010 Oct;37(5):539-45. doi: 10.1016/j.anl.2010.02.009. Review.

PMID:
20399579
10.

Association between benign and malignant peripheral nerve sheath tumors in NF1.

Tucker T, Wolkenstein P, Revuz J, Zeller J, Friedman JM.

Neurology. 2005 Jul 26;65(2):205-11.

PMID:
16043787
11.

Malignant peripheral nerve sheath tumor: analysis of treatment outcome.

Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL.

Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):351-60.

PMID:
9788415
12.

Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.

Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE.

J Neurosurg. 2017 Jan;126(1):319-329. doi: 10.3171/2015.12.JNS152443. Epub 2016 Apr 1.

13.

Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.

Vasconcelos RAT, Coscarelli PG, Alvarenga RP, Acioly MA.

Arq Neuropsiquiatr. 2017 Jun;75(6):366-371. doi: 10.1590/0004-282X20170052.

14.

Malignant triton tumors--complete surgical resection and adjuvant radiotherapy associated with improved survival.

McConnell YJ, Giacomantonio CA.

J Surg Oncol. 2012 Jul 1;106(1):51-6. doi: 10.1002/jso.23042. Epub 2012 Jan 17.

PMID:
22253011
15.

Long survival after resection for lung metastasis of malignant peripheral nerve sheath tumor in neurofibromatosis 1.

Shimizu K, Okita R, Uchida Y, Hihara J.

Ann Thorac Cardiovasc Surg. 2008 Oct;14(5):322-4.

PMID:
18989250
16.

[A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].

Malerba M, Garofalo A.

Tumori. 2003 Jul-Aug;89(4 Suppl):246-50. Italian.

PMID:
12903608
17.

Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.

Montano N, D'Alessandris QG, D'Ercole M, Lauretti L, Pallini R, Di Bonaventura R, La Rocca G, Bianchi F, Fernandez E.

J Neurosurg. 2016 Aug;125(2):363-71. doi: 10.3171/2015.6.JNS15596. Epub 2015 Dec 4.

PMID:
26636382
18.

Neurological outcomes and surgical complications in 221 spinal nerve sheath tumors.

Safaee MM, Lyon R, Barbaro NM, Chou D, Mummaneni PV, Weinstein PR, Chin CT, Tihan T, Ames CP.

J Neurosurg Spine. 2017 Jan;26(1):103-111. doi: 10.3171/2016.5.SPINE15974. Epub 2016 Jul 29.

PMID:
27472744
19.

Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.

Endo M, Yamamoto H, Setsu N, Kohashi K, Takahashi Y, Ishii T, Iida K, Matsumoto Y, Hakozaki M, Aoki M, Iwasaki H, Dobashi Y, Nishiyama K, Iwamoto Y, Oda Y.

Clin Cancer Res. 2013 Jan 15;19(2):450-61. doi: 10.1158/1078-0432.CCR-12-1067. Epub 2012 Dec 3.

20.

Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience.

Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, Wasif N.

Ann Surg Oncol. 2012 Mar;19(3):878-85. doi: 10.1245/s10434-011-1978-7. Epub 2011 Aug 23.

PMID:
21861229

Supplemental Content

Support Center